STAT3, increasingly recognized for its role in cellular lipid uptake [27,51], has been shown to normalize lipid uptake when targeted, thus offering a potential target for addressing lipid-related metabolic disorders [52,53,54]. This evidence concerns the gene STAT3 and Other metabolic disease.